RESUMEN
All widely used mRNA vaccines against COVID-19 contain in their sequence 1-methylpseudouridine (m1Ψ) instead of uridine. In this publication, we report two high resolution crystal structures (at up to 1.01 and 1.32â Å, respectively) of one such double-stranded 12-mer RNA sequence crystallized in two crystal forms. The structures are compared with similar structures which do not contain this modification. Additionally, the X-ray structure of 1-methyl-pseudouridine itself was determined.
Asunto(s)
Seudouridina , Seudouridina/análogos & derivados , ARN , Humanos , Seudouridina/química , Vacunas de ARNm , Vacunas contra la COVID-19RESUMEN
The Nano-Crystallization method has been extensively tested for the growth of single crystals of cationic coordination compounds, which are soluble in water. All three studied, diverse metal complexes could be crystallized with the help of pipetting robots commonly used for the crystallization of proteins and the anion small molecule screen. It was furthermore possible to obtain for each positively charged complex several structures with different anions. In one case, together with literature data, a total of six salts with different anions could be assembled, which allowed an investigation of the influence of the counterions on the inter-cation metal-to-metal distance. The Nano-Crystallization method can be recommended for the single crystal growth of cationic coordination complexes, which are stable in water and have an aqueous solubility of at least 2 mM. This is the first publication dedicated solely to the single crystal growth of coordination complexes.
RESUMEN
Multicomponent solid forms of active pharmaceutical ingredients represent a modern method of tuning their physicochemical properties. Typically, salts are the most commonly used multicomponent solid form in the pharmaceutical industry. More than 38% are formulated as organic cations. Salt screening is an essential but demanding step when identifying the most appropriate formulation. The microbatch under-oil crystallization technique of proteins has been combined with the previously developed high-throughput vapour-diffusion screening for use as a novel method of primary salt screening of organic cations. The procedure allows the set up of about 100 crystallization experiments per 30â min. This requires between 17 and 564â mg of screened cationic active pharmaceutical ingredients, which were of moderate to very high water solublity. Five distinct organic salts, three of them diverse active pharmaceutical compounds or the other enantiomer thereof, in the form of chloride salts were tested. The screening was extremely successful; at least two new single-crystal structures could be obtained for each particular compound and many more salts as single crystals were formed compared with our previous vapour-diffusion method.
RESUMEN
The generation of solid salts of organic molecules is important to the chemical and pharmaceutical industry. Commonly used salt screening methods consume a lot of resources. We employed a combination of ion exchange screening and vapour diffusion for crystallization. This technique is semi-automatic and requires just nanoliters of the solution of the analyte to be crystallized. This high throughput screening yielded single crystals of sufficient size and quality for single-crystal X-ray structure determination using an in-house X-ray diffractometer. The broad scope of our method has been shown by challenging it with 7 very different organic cations, whose aqueous solubilities vary by a factor of almost 1000. At least one crystal structure for 6 out of 7 tested cations was determined; 4 out of the successful 6 ones had never been crystallized before. Our method is extremely attractive for high throughput salt screening, especially for active pharmaceutical ingredients (APIs), as about 40% of all APIs are cationic salts. Additionally, our screening is a new and very promising procedure for the crystallization of salts of organic cations.